These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 4637029
1. Estrogenic activity in women receiving an injectable progestogen for contraception. Mishell DR, Kharma KM, Thorneycroft IH, Nakamura RM. Am J Obstet Gynecol; 1972 Jun 01; 113(3):372-6. PubMed ID: 4637029 [Abstract] [Full Text] [Related]
2. Endometrial histology and circulating levels of medroxyprogesterone acetate (MPA), estradiol, FSH and LH in women with MPA induced amenorrhoea compared with women with secondary amenorrhoea. Jeppsson S, Johansson ED, Ljungberg O, Sjöberg NO. Acta Obstet Gynecol Scand; 1977 Jun 01; 56(1):43-8. PubMed ID: 842303 [Abstract] [Full Text] [Related]
3. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA. J Clin Endocrinol Metab; 1996 Nov 01; 81(11):4113-21. PubMed ID: 8923869 [Abstract] [Full Text] [Related]
4. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding. Lemay A, Faure N, Labrie F, Fazekas AT. Fertil Steril; 1985 Jun 01; 43(6):868-77. PubMed ID: 3158551 [Abstract] [Full Text] [Related]
5. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel. Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U. Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174 [Abstract] [Full Text] [Related]
6. Control of fertility with oral medication. Diddle AW, Watts GF, Gardner WH, Williamson PJ. West J Surg Obstet Gynecol; 1964 Sep 15; 72():222-9. PubMed ID: 12305556 [Abstract] [Full Text] [Related]
7. The effect of contraceptive steroids on hypothalamic-pituitary function. Mishell DR, Kletzky OA, Brenner PF, Roy S, Nicoloff J. Am J Obstet Gynecol; 1977 May 01; 128(1):60-74. PubMed ID: 403765 [Abstract] [Full Text] [Related]
8. Sustained effects on synthetic ovarian steroids of rat myometrial contractility. Parkington HC, Lipton A. J Endocrinol; 1976 Aug 01; 70(2):223-7. PubMed ID: 965882 [Abstract] [Full Text] [Related]
9. Serum follicle-stimulating hormone, luteinizing hormone and progesterone concentrations in pseudopregnant rats treated with medroxyprogesterone acetate. de Greef WJ, Dullaart J, Zeilmaker GH. J Endocrinol; 1976 Sep 01; 70(3):465-71. PubMed ID: 978105 [Abstract] [Full Text] [Related]
10. Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration. Hiroi M, Stanczyk FZ, Goebelsmann U, Brenner PF, Lumkin ME, Mishell DR. Steroids; 1975 Sep 01; 26(3):373-86. PubMed ID: 1198624 [Abstract] [Full Text] [Related]
11. Return of ovulation following a single injection of depo-medroxyprogesterone acetate: a pharmacokinetic and pharmacodynamic study. Lan PT, Aedo AR, Landgren BM, Johannisson E, Diczfalusy E. Contraception; 1984 Jan 01; 29(1):1-18. PubMed ID: 6234145 [Abstract] [Full Text] [Related]
12. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone. Goebelsmann U, Stanczyk FZ, Brenner PF, Goebelsmann AE, Gentzschein EK, Mishell DR. Contraception; 1979 Mar 01; 19(3):283-313. PubMed ID: 572279 [Abstract] [Full Text] [Related]
13. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment. Soufir JC, Jouannet P, Marson J, Soumah A. Acta Endocrinol (Copenh); 1983 Apr 01; 102(4):625-32. PubMed ID: 6221496 [Abstract] [Full Text] [Related]
14. Studies on ovarian and adrenal steroids at different phases of the menstrual cycle. III. Steroid and lutropin levels before and after the administration of a single contraceptive dose of depot-medroxyprogesterone acetate (DMPA). Aedo AR, Landgren BM, Diczfalusy E. Contraception; 1981 Aug 01; 24(2):117-35. PubMed ID: 6457729 [Abstract] [Full Text] [Related]
15. Mammary tumors and serum hormones in the bitch treated with medroxyprogesterone acetate or progesterone for four years. Frank DW, Kirton KT, Murchison TE, Quinlan WJ, Coleman ME, Gilbertson TJ, Feenstra ES, Kimball FA. Fertil Steril; 1979 Mar 01; 31(3):340-6. PubMed ID: 437169 [Abstract] [Full Text] [Related]
16. Plasma levels of estrogens during long-term treatment with depo-medroxyprogesterone acetate as a contraceptive agent. Jeppsson S, Johansson ED, Sjörberg NO. Contraception; 1973 Aug 01; 8(2):165-70. PubMed ID: 4768085 [Abstract] [Full Text] [Related]
17. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate. Furuhjelm M, Carlström K. Acta Obstet Gynecol Scand; 1977 Aug 01; 56(4):351-61. PubMed ID: 602703 [Abstract] [Full Text] [Related]
18. Acceptability of injectable contraceptives in Assiut, Egypt. Salem HT, Salah M, Aly MY, Thabet AI, Shaaban MM, Fathalla MF. Contraception; 1988 Dec 01; 38(6):697-710. PubMed ID: 2975583 [Abstract] [Full Text] [Related]
19. A preliminary pharmacological trial of the monthly injectable contraceptive cycloprovera. Fotherby K, Benagiano G, Toppozada HK, Abdel-Rahman A, Navaroli F, Arce B, Ramos-Cordero R, Gual C, Landgren BM, Johannisson E. Contraception; 1982 Mar 01; 25(3):261-72. PubMed ID: 6210485 [Abstract] [Full Text] [Related]
20. Pharmacokinetic study of different doses of Depo Provera. Fotherby K, Koetsawang S, Mathrubutham M. Contraception; 1980 Nov 01; 22(5):527-36. PubMed ID: 6451351 [Abstract] [Full Text] [Related] Page: [Next] [New Search]